CEP-32496: a novel orally active BRAF(V600E) inhibitor with selective cellular and in vivo antitumor activity
CEP-32496：一种新型口服 BRAF（V600E）抑制剂，具有选择性细胞和体内抗肿瘤活性
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-11-0645
Joyce James, Bruce Ruggeri, Robert C Armstrong, Martin W Rowbottom, Susan Jones-Bolin, Ruwanthi N Gunawardane, Pawel Dobrzanski, Michael F Gardner, Hugh Zhao, Merryl D Cramer, Kathryn Hunter, Ronald R Nepomuceno, Mangeng Cheng, Dana Gitnick, Mehran Yazdanian, Darren E Insko, Mark A Ator, Julius L Ap
